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Intramolecular arylation of benzimidazoles via Pd(II)/Cu(I)
catalyzed cross-dehydrogenative coupling
Kyle C. Pereira, Ashley L. Porter, and Brenton DeBoef*
Department of Chemistry, University of Rhode Island, Kingston, RI 02881, USA

Abstract
Electron poor benzimidazole substrates were arylated via an intramolecular cross-dehydrogenative
coupling (CDC) reaction. These CDC reactions were catalyzed by a Pd(II)/Cu(I) catalyst system,
capable of producing moderate yields on a large library of substrates. The substrate scope
consisted of tethered arene-benzimidazoles that upon coupling, produced a fused polycyclic motif.
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The biaryl motif is a prominent structure in many biologically active compounds, and green
methods to synthesize these biaryl bonds are highly desired.1 Conventional aryl coupling
methods (i.e. Suzuki-Miyaura2 or Stille3 coupling) employ prefunctionalization steps to
form activated C–metal or C–halogen bonds, which can readily undergo catalytic coupling.
However, this prefunctionalization decreases the overall step economy of the synthesis and
produces large amounts of waste. A far more advantageous coupling method would be
cross-dehydrogenative coupling (CDC). It can be used to inter- and intramolecularly couple
two aryl hydrocarbon bonds, requiring no prefunctionalization of substrates and affording
high yields with minimal byproducts and waste (Scheme 1).
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Much attention has been given to incorporating heterocycles into biaryl CDC reactions,
since heterocyclic components are often found in nature and play a prominent role in
pharmaceutical candidates.1 The benzimidazole moiety alone has been shown to have many
important uses including an antiviral for HIV,4 antibacterials5–6 and possible anticancer
agents.7 However, imidazoles are rarely found as a coupling substrates in CDC reactions.
Mori and coworkers have shown an efficient homocoupling reaction for imidazoles,8 and the
You group has found success coupling imidazoles to thiophenes,9–10 but CDC between
imidazoles and benzenes has proved to be a challenging task. Dominguez and Dubois have
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arylated imidazoles using aryl iodides,11–12 but, to our knowledge, the only examples of
coupling imidazoles with simple arenes via CDC are the recent examples of Bao and Guo.13
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With this in mind, we decided to explore palladium catalyzed CDC reactions between
benzimidazoles and arenes. To help overcome coupling difficulties, the arene was tethered
to the benzimidazole prior to coupling by installing an N-benzyl substituent. The tether
would help in the metalation of both coupling partners by keeping them in close proximity
to each other, and at the same time reducing unwanted dimerization. CDC should cause this
tethered substrate to cyclize into a fused polycyclic system.
The optimization studies for this reaction were performed on N-benzyl benzimidazole,
substrate 1, which was synthesized through a substitution reaction using deprotonated
benzimidazole and benzyl chloride. Substrate 1 was then purified by column
chromatography and afforded a 70% yield. Initially, we thought that a Cu(I) salt would be a
beneficial catalyst since it has been shown that CuI can arylate the C2 position of azoles via
intramolecular coupling with aryl iodides.11 Since 1 did not contain a halogen, it was also
theorized that a catalyst such as Pd(OAc)2 would be needed to activate the aryl C–H bond.
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However both Pd(OAc)2/CuI and Pd(OAc)2/CuCl catalyst systems proved to be ineffective,
since they both gave low conversion of starting materials and a mixture of byproducts. Next,
a rhodium based catalyst, [RhCl(coe)2]2, was tried, but it suffered from low yields and
dimerization. Simply using Pd(OAc)2 as the catalyst with a Cu(OAc)2·H2O oxidant
provided a superior system; therefore, further optimization reactions were run with this
catalyst system (Table 1).
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At the outset, undesired byproducts including the dimer 4 and the acetoxylated compound 3
plagued the reaction. It was found that lowering the amount of Cu(OAc)2·H2O oxidant
helped reduce the amount of acetoxylated products since the amount of acetate anion was
reduced. Also lowering the temperature and time of the reaction helped lower byproduct
formation. Interestingly, the addition of CsOPiv (Table 1, entry 5) eliminated compound 3,
most likely due to the steric nature of the pivalate anion. It has been suggested by Fagnou
that the addition of pivalate helps facilitate C-H bond cleavage by forming Pd(OPiv)2 prior
to palladation.14–16 Fagnou and coworkers also showed that reactions performed in pivalic
acid instead of acetic acid greatly reduced unwanted oxidative byproducts including
dimers.14
Upon doubling the amount of Pd(OAc)2, compound 2 was recovered in a nearly double
yield (Table 1, entry 6), suggesting that catalyst turnover was a problem in the reaction.
After many trials, the optimal time and temperature for the coupling reaction was found to
be 3 hours at 150 °C using microwave heating (Table 1, entry 8). The longer reaction times
led to a decrease in product yield, perhaps due to decomposition (Table 1, entry 9). Finally,
we were excited to discover that the addition of 0.5 equivalents of CuOAc improved the
yield slightly, producing the best isolated yield of 58% (Table 1, entry 10).
Another interesting observation during the optimization of this reaction was the copper color
present in the organic layer while extracting the product. Cu(II) has been known to
coordinate to pyrazole ligands in isolatable complexes;17 thus we speculated that copper was
Tetrahedron Lett. Author manuscript; available in PMC 2015 March 05.
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forming a complex with our benzimidazole products, and therefore lowering the isolated
yield. A stronger ligand was perhaps needed to coordinate to the copper and liberate the
final product. Immediately following the coupling reaction, Na2S·9H2O was added to the
reaction and stirred at room temperature for an hour. This removed all copper color from the
organic extract, and simultaneously increased the yields of the coupled product.
Next, an array of substrates was screened with the optimized conditions to determine the
scope of the reaction (Table 2). The presence of an electron donating group on the
benzimidazole moiety increased the coupling yield, as evidenced by comparing compounds
2, 5, 16 and 17, and electron withdrawing functionalities on the benzimidazole (9) seemed to
hinder coupling. When comparing electron rich and electron poor arene coupling partners,
there didn’t appear to be a significant trend in reactivity. The starting materials for products
8, 9 and 13 were synthesized in inseparable mixtures, thus the cyclization reactions
produced mixtures of isomers. The cyclization was successful in forming a new sixmembered ring, compound 21, but failed to couple compounds 19 and 20, which would have
produced seven membered rings. This indicated that the length of the tether highly
influenced the success of the reaction.
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Intramolecular coupling reactions between benzimidazole and other heterocycles, such as
furan, imidazole, and the caffeine derivative, benzyl theophylline, were also tried under our
optimized conditions; however, the attempts were unsuccessful (12, 14 and 22, Table 2).
Kinetic isotope effects of the reaction were evaluated by carrying out competition studies.
The first competition study employed equimolar amounts of N-benzylbenzimidazole and
deuterated N-benzyl-d7-benzimidazole, and subjected both substrates to the optimized
coupling conditions. Relative amounts of the products were obtained from GC-MS analysis
and a KIE of 1.03 was obtained (Scheme 2). This indicated that the metalation of the arene
coupling partner was facile and not rate limiting.18 A second competition study was carried
out with equimolar amounts of N-benzylbenzimidazole and N-benzyl-2deuterobenzimidazole, but the KIE results of this test proved to be inconclusive due to H/D
scrambling.
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With the KIE studies in hand, we sought to propose a plausible mechanism for this unique
intramolecular CDC reaction. Based on all data, it seemed that the coupling was taking place
through a PdII/CuI catalyzed system. Our reasoning behind the dual metal catalysis was
supported by several factors. It was known from previous studies that Cu(I) was capable of
enhancing azole coupling,8–11 so we speculated that Cu(I) was needed to activate the C2
position of the benzimidazole. Because the addition of Cu(I) only raised the percent yield
slightly (Table 1, entry 10), we needed to be sure that the addition of Cu(I) was essential in
the formation of the product. Since the Cu(OAc)2 oxidant could disproportionate into Cu(I),
we theorized that there was perhaps some Cu(I) present to catalyze the reaction even in the
absence of added CuOAc. This would explain why we did not see a significant raise in yield
upon the addition of a Cu(I) source.
To further test whether Cu(I) was involved in the mechanism, we had to eliminate the use of
Cu(OAc)2 as an oxidant (Scheme 3). A control reaction was carried out using AgOAc as an
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oxidant and Pd(OAc)2 as the only catalyst. The GC-MS results showed that there was low
conversion of the starting material into a small amount of the acetoxylated product 3 and
dimer 4. None of the desired arylation product 2 was observed, though it is the presumed
precursor of 3. This indicated that the Pd(II) catalyst was capable of metallating both the C2
position of the benzimidazole and the ortho carbon of the tethered arene. However, the low
conversion indicated that this process, involving two C–H palladations, was not likely the
mechanism by which the reactions shown in Table 2 occurred.
We next ran a second control using only a Cu(I) catalyst and AgOAc as the oxidant. The
GC-MS results showed there was a low conversion of the starting material into the dimer 4
(Scheme 3). Consequently, we concluded that Cu(I) could activate the benzimidazole moiety
and form the benzimidazole dimer. This control reaction also indicated that Pd played a
pivotal role in the activation of the arene for coupling.
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Our proposed mechanism (Scheme 4) utilizes two independent metalation steps. First, Cu(I)
inserts in the 2-position of benzimidazole, forming acetic acid and a Cu(I)-benzimidazole
complex. Next, the arene is palladated, again producing acetic acid as a byproduct. At this
point, a transmetalation could occur in which CuOAc is released and a biaryl Pd(II) complex
is formed. The final step of the reaction would include a simple reductive elimination to
form the coupled aryl-benzimidazole product and Pd(0). Subsequent oxidation of the Pd by
the Cu(OAc)2 oxidant would regenerate both the Pd(II) and Cu(I) catalysts. To our
knowledge, two independent C–H activations by different metals followed by a
transmetalation, is an intriguing mechanism, and would warrant future investigations.
In conclusion, we have developed an intramolecular coupling reaction between the 2position of benzimidazole and a tethered arene to form fused polycyclic heterocycles. The
use of cross-dehydrogenative coupling in this reaction makes it highly atom economical and
cost efficient, since no prefunctionalization is required. Mechanistic investigations led us to
propose that the reaction proceeds via a dual PdII/CuI catalyst system with a Cu(OAc)2
oxidant. A large library of electron poor and electron rich arene-benzimidazoles were
coupled in moderate yields, suggesting that this reaction could be a valuable tool in the
synthesis of biologically useful heterocyclic compounds.
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Scheme 1.
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The conventional Suzuki-Miyaura cross-coupling method vs. CDC
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Scheme 2.

KIE study of the intramolecular benzimidazolearene CDC19

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Tetrahedron Lett. Author manuscript; available in PMC 2015 March 05.

Pereira et al.

Page 8

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Scheme 3.

Control reactions using AgOAc as an oxidant19
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Scheme 4.

Proposed mechanism for the Pd(II)/Cu(I) catalyzed cyclization of N-benzylbenzimdazoles
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Optimization of the reaction conditions
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Table 1
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Table 2
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Scope of the Cyclization of N-benzylbenzimidazolesa
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a

Reaction conditions: 0.384 mmol substrate, 20 mol % Pd(OAc)2, Cu(OAc)2•H2O (0.768 mmol), CuOAc (0.192 mmol), CsOPiv (0.960 mmol) in

5 mL of 1,4-dioxane at 150 °C for 3 hr under microwave heating. Isolated yields following work-up with Na2S·9H2O. See supporting information
for a representative procedure.
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b

A small amount of the desired product was detected by GC-MS.

c

Only starting materials were observed by GC-MS.

d
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The starting material was completely consumed, but the desired product was not observed.
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